Publications Database

Anagnostou E. et al. (2014)

Autism spectrum disorder: advances in evidence-based practice.

Canadian Medical Association Journal

186(7),

Read Full (New Window)

Anagnostou E.

Clinical trials in autism spectrum disorder: evidence, challenges and future directions.

Current Opinion in Neurology

Read Abstract (New Window)

Anagnostou E. et al. (2006)

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.

Journal of Clinical Psychopharmacology

26(4), pp. 444-446

Anagnostou E. et al. (2014)

Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth.

Brain Research

pii: S0006-8993(14)00134-6

Read Abstract (New Window)

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Anagnostou E. et al.

Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial.

JAMA Psychiatry

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

An update on medication management of behavioral disorders in autism.

Current Psychiatry Reports

16(3), pp. 437

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

Social communication is an emerging target for pharmacotherapy in autism spectrum disorder: A review of the literature on potential agents.

Journal of Canadian Academic Child Adolescent Psychiatry

23(1), pp. 20-30.

Read Abstract (New Window) Read Full (New Window)

Coury D. et al. (2012)

Use of psychotropic medication in children and adolescents with autism spectrum disorders.

Pediatrics

130 S69-76.

Read Abstract (New Window) Read Extract (New Window)

Goldfarb C. et al. (2016)

Hyperbaric oxygen therapy for the treatment of children and youth with autism spectrum disorders: An evidence-based systematic review.

September, 29 pp. 1-7.

Read Abstract (New Window)

Hollander E. et al. (2012)

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

American Journal of Psychiatry

169(3), pp. 292-299.

Read Abstract (New Window)

Hollander E. et al. (2006)

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

International Journal of Neuropsycholpharmacology

9(2), pp. 209-213

Read Abstract (New Window)

Hollander E. et al. (2007)

Oxytocin increases retention of social cognition in autism.

Biological Psychiatry

61(4), pp. 498-503

Read Abstract (New Window) Read Full (New Window)

King B. H. et al. (2013)

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: A multisite randomized clinical trial.

JAMA Pediatrics

November, 167(11),

Read Abstract (New Window)

King B. H. et al. (2009)

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

Archives of General Psychiatry

66(6), pp. 583-590

Read Abstract (New Window)

Mahajan R. et al. (2012)

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Pediatrics

130 S125-138

Read Abstract (New Window) Read Full (New Window)

Mankad D. et al. (2015)

A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism.

Molecular Autism

Read Abstract (New Window) Read Full (New Window)

Smile S. , Anagnostou E. (0000)

New models for considering the role of medication in the treatment and elucidation of the etiology of autism.

Current Psychiatry Reports

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)